Investigation of the impact of gynoid fat on steatotic and advanced liver diseases–Genomic and clinical perspectives from a large-scale population cohort
Clinical Nutrition · 2025
DOI: 10.1016/j.clnu.2025.11.012 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Nutrition, 2025. Verfasst von Zhengye Liu und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Plastic and Aesthetic Center, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China. Hauptthemen laut MEDLINE: Non-alcoholic Fatty Liver Disease, Adiposity, Fatty Liver. Die Arbeit nennt 39 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Zhejiang Province Natural Science Foundation, Chinese Academy of Meteorological Sciences.
Abstract (Originalsprache)
BACKGROUND AND AIMS: Gynoid fat (hip-thigh subcutaneous adiposity) is metabolically favorable, yet its genetic architecture and impact on liver diseases are unknown. We aimed to identify genetic determinants of gynoid tissue fat percentage (GTFP) and explore their clinical implications to liver disease. METHODS: We conducted a genome-wide association study (GWAS) in 37,385 European individuals from the UK Biobank to identify genetic variants associated with GTFP. A polygenic risk score (PRS) was then derived for GTFP. Post-GWAS analyses, including colocalization, transcriptome-wide association studies (TWAS), logistic regression models, and interaction analyses, were employed to assess the impact of GTFP indicated by PRS on alcoholic and non-alcoholic fatty liver disease (NAFLD), metabolic dysfunction associated steatotic liver disease (MASLD), liver fibrosis and liver cancer. RESULTS: Our GWAS identified 18 significant genetic variants that were associated with GTFP. Colocalization and TWAS highlighted shared signals with adipose gene expression at RSPO3, CCND1, and MYEOV et al. Integrative single-cell analysis revealed that candidate genes were mostly enriched in adipogenic progenitors, macrophages, myeloid cells and mature adipocytes. GTFP PRS showed negative correlation with metabolic traits that are crucial for steatotic liver disease development. GTFP PRS was associated with a reduced risk of NAFLD (OR = 0.97 [95 % CI 0.95-0.99], p = 0.017), liver fibrosis (OR = 0.97 [95 % CI 0.94-1.00], p = 0.029) and MASLD defined by either fatty liver index (OR = 0.94 [95 % CI 0.91-0.97], p < 0.001) or liver proton density fat fraction (OR = 0.95 [95 % CI 0.947-0.953], p < 0.001) and the decline of indices reflecting hepatic steatosis in MASLD population. No significant associations were observed for alcoholic liver disease and liver cancer. The restricted cubic spline regression suggested a linear relationship between GTFP PRS and MASLD risk, but not for other liver diseases. GTFP PRS plays stronger effects among individuals with healthier metabolic status and higher physical activity, but were independent of PNPLA3-rs738409 and TM6SF2-rs58542926. CONCLUSIONS: We delineate the genetic landscape of gynoid fat and provide evidence that higher GTFP, proxied by PRS, protects against NAFLD, MASLD and liver fibrosis, supporting adipose-targeted strategies for prevention and risk stratification.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Plastic and Aesthetic Center, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
- Department of Gastroenterology, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
- Department of Endocrinology, Key Laboratory of Endocrinology of National Health Commission, Translation Medicine Centre, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sc…
- Department of Radiation Oncology, National Cancer Center, Cancer Hospital, National Clinical Research Center for Cancer, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China; Tsinghua Uni…
- Institute of Clinical Medicine, National Infrastructures for Translational Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China.
- Vanke School of Public Health and Institute for Healthy China, Tsinghua University, Beijing, China.
Förderung
- National Natural Science Foundation of China
- Zhejiang Province Natural Science Foundation
- Chinese Academy of Meteorological Sciences
- Chinese Academy of Medical Sciences Initiative for Innovative Medicine
Zitieren
APA
Liu, Z., Chen, H., Du, H., Lin, G., Tu, T., Wan, Z., Zhao, N., Li, G., Tang, B., Wu, H., Bai, X., Wang, Q. L., & Mi, J. (2025). Investigation of the impact of gynoid fat on steatotic and advanced liver diseases–Genomic and clinical perspectives from a large-scale population cohort. Clinical Nutrition. https://doi.org/10.1016/j.clnu.2025.11.012
Vancouver
Liu Z, Chen H, Du H, Lin G, Tu T, Wan Z, et al. Investigation of the impact of gynoid fat on steatotic and advanced liver diseases–Genomic and clinical perspectives from a large-scale population cohort. Clinical Nutrition. 2025. doi:10.1016/j.clnu.2025.11.012
BibTeX
@article{Liu2025,
author = {Liu, Zhengye and Chen, Haotian and Du, Hanze and Lin, Guang and Tu, Tian and Wan, Ziqi and Zhao, Nan and Li, Guanqiao and Tang, Bowen and Wu, Huilin and Bai, Xiaoyin and Wang, Qiao-Li and Mi, Jiarui},
title = {Investigation of the impact of gynoid fat on steatotic and advanced liver diseases–Genomic and clinical perspectives from a large-scale population cohort},
journal = {Clinical Nutrition},
year = {2025},
doi = {10.1016/j.clnu.2025.11.012}
}
EUVIMED